Caribou Biosciences, Inc. (CRBU)
Total Valuation
CRBU has a market cap or net worth of $464.22 million. The enterprise value is $162.50 million.
Market Cap | 464.22M |
Enterprise Value | 162.50M |
Important Dates
The last earnings date was Monday, March 11, 2024, after market close.
Earnings Date | Mar 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CRBU has 90.31 million shares outstanding. The number of shares has increased by 21.39% in one year.
Shares Outstanding | 90.31M |
Shares Change (YoY) | +21.39% |
Shares Change (QoQ) | -11.91% |
Owned by Insiders (%) | 12.42% |
Owned by Institutions (%) | 80.33% |
Float | 68.48M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 13.46 |
Forward PS | 39.58 |
PB Ratio | 1.26 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 4.71 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.97, with a Debt / Equity ratio of 0.07.
Current Ratio | 11.97 |
Quick Ratio | 11.70 |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -31.10% and return on invested capital (ROIC) is -29.34%.
Return on Equity (ROE) | -31.10% |
Return on Assets (ROA) | -25.70% |
Return on Capital (ROIC) | -29.34% |
Revenue Per Employee | $218,209 |
Profits Per Employee | -$646,013 |
Employee Count | 158 |
Asset Turnover | 0.09 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CRBU has paid $193,000 in taxes.
Income Tax | 193,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.67% in the last 52 weeks. The beta is 2.59, so CRBU's price volatility has been higher than the market average.
Beta (1Y) | 2.59 |
52-Week Price Change | +8.67% |
50-Day Moving Average | 6.34 |
200-Day Moving Average | 5.67 |
Relative Strength Index (RSI) | 35.71 |
Average Volume (30 Days) | 1,619,891 |
Short Selling Information
The latest short interest is 10.07 million, so 11.15% of the outstanding shares have been sold short.
Short Interest | 10.07M |
Short Previous Month | 9.39M |
Short % of Shares Out | 11.15% |
Short % of Float | 14.71% |
Short Ratio (days to cover) | 5.95 |
Income Statement
In the last 12 months, CRBU had revenue of $34.48 million and -$102.07 million in losses. Loss per share was -$1.38.
Revenue | 34.48M |
Gross Profit | 34.48M |
Operating Income | -116.06M |
Pretax Income | -101.88M |
Net Income | -102.07M |
EBITDA | -96.30M |
EBIT | -101.88M |
Loss Per Share | -$1.38 |
Balance Sheet
The company has $328.83 million in cash and $27.11 million in debt, giving a net cash position of $301.72 million or $3.34 per share.
Cash & Cash Equivalents | 328.83M |
Total Debt | 27.11M |
Net Cash | 301.72M |
Net Cash Per Share | $3.34 |
Equity / Book Value | 368.40M |
Book Value Per Share | 4.08 |
Working Capital | 310.54M |
Cash Flow
In the last 12 months, operating cash flow was -$93.29 million and capital expenditures -$11.61 million, giving a free cash flow of -$104.90 million.
Operating Cash Flow | -93.29M |
Capital Expenditures | -11.61M |
Free Cash Flow | -104.90M |
FCF Per Share | -$1.42 |
Margins
Gross margin is 100.00%, with operating and profit margins of -336.63% and -296.05%.
Gross Margin | 100.00% |
Operating Margin | -336.63% |
Pretax Margin | -295.49% |
Profit Margin | -296.05% |
EBITDA Margin | -279.33% |
EBIT Margin | -295.49% |
FCF Margin | -304.27% |
Dividends & Yields
CRBU does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -21.39% |
Shareholder Yield | -21.39% |
Earnings Yield | -21.99% |
FCF Yield | -22.60% |
Analyst Forecast
The average price target for CRBU is $22.00, which is 328.02% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $22.00 |
Price Target Difference | 328.02% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 59.94% |
EPS Growth Forecast (5Y) | -11.37% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CRBU has an Altman Z-Score of 3.56 and a Piotroski F-Score of 4.
Altman Z-Score | 3.56 |
Piotroski F-Score | 4 |